Search

everythinglearnresearchcommunity

for

Search:↓

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

The gel improves hair regrowth and reduces irritation in alopecia areata treatment.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Scarless healing is complex and influenced by genetics and environment, while better understanding could improve scar treatment.

Bioengineered scaffolds help heal skin wounds, but perfect treatments are still needed.

Dandruff is a common, winter-worsened scalp condition linked to inflammation and microorganisms, treatable with products like ketoconazole, and may affect hair loss.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Severe alopecia areata in South Korea has a high treatment burden, with most patients needing multiple treatments and frequent doctor visits.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Topical Vorinostat shows promise for treating alopecia areata by promoting hair regrowth.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

Ivermectin with supportive therapies effectively treats canine demodicosis.

Embryonic and adult stem cells are valuable for improving skin grafts and cell therapy.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.